APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +164.0% | +87.8% | +24.3% | |
| – | +162.0% | +33.0% | +40.0% | |
| – | -22.1% | +19.8% | -7.2% | |
| – | +160.4% | +31.7% | +40.2% | |
| – | – | +286.9% | +26.9% | |
| – | +115.3% | +72.9% | -10.5% | |
| – | +106.0% | +38.9% | -2.3% | |
| – | – | +193.7% | +8.3% | |
| – | +412.7% | -50.0% | +14.0% | |
| – | +167.4% | +88.7% | +26.1% | |
| – | – | – | – | |
| – | 0.0% | +9.0% | +10.0% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.